Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly Other Working Capital Changes came in at -$864000.0 in Q1 2026, down 214.29% year-on-year from $756000.0 in Q1 2025, and down 290.73% quarter-over-quarter from $453000.0 in Q4 2025.
Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Other Working Capital Changes across 4 years of filings, most recently posting -$864000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$864000.0, down 214.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (up 44.12% YoY), and the FY2025 annual result was $6.2 million, up 46.2% from the prior year.
- Other Working Capital Changes came in at -$864000.0 for Q1 2026 at Immunocore Holdings, down from $453000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $18.4 million in Q3 2023 to a low of -$18.1 million in Q1 2023.
- The 4-year median for Other Working Capital Changes is $756000.0 (2025), against an average of $1.4 million.
- Across the five-year window, Other Working Capital Changes surged 256.21% in 2025 and slumped 214.29% in 2026, its largest moves.
- Immunocore Holdings' Other Working Capital Changes stood at $6.5 million in 2023, then plunged by 104.47% to -$290000.0 in 2024, then soared by 256.21% to $453000.0 in 2025, then sank by 290.73% to -$864000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$864000.0 (Q1 2026), $453000.0 (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -864,000.00 |
| Mar 31, 2026 | -864,000.00 |
| Dec 31, 2025 | 453,000.00 |
| Dec 31, 2025 | 453,000.00 |
| Sep 30, 2025 | 6.25 Mn |
| Sep 30, 2025 | 6.25 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | 756,000.00 |
| Mar 31, 2025 | 756,000.00 |
| Dec 31, 2024 | -290,000.00 |
| Dec 31, 2024 | -290,000.00 |
| Sep 30, 2024 | 4.61 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Dec 31, 2023 | 6.49 Mn |